News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,133 Results
Type
Article (27)
Press Release (3106)
Section
Business (1334)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (267)
News (2104)
Policy (116)
Tag
Academia (3)
Allergies (1)
Alliances (44)
Alzheimer's disease (29)
Approvals (107)
Artificial intelligence (1)
Best Places to Work (297)
Breast cancer (9)
Cancer (76)
Career advice (1)
Clinical research (652)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (90)
Diabetes (1)
Diagnostics (22)
Drug discovery (1)
Drug pricing (1)
Earnings (1445)
Events (340)
FDA (134)
Frontotemporal dementia (1)
Funding (4)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (10)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (161)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (1)
Legal (1)
Lung cancer (29)
Lymphoma (10)
Manufacturing (1)
MASH (4)
Medical device (56)
Medtech (56)
Mergers & acquisitions (25)
Metabolic disorders (6)
Multiple sclerosis (3)
NASH (1)
Neuroscience (37)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Peanut (1)
People (8)
Phase I (98)
Phase II (197)
Phase III (386)
Pipeline (60)
Policy (1)
Postmarket research (27)
Preclinical (12)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (5)
Regulatory (145)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (1)
Schizophrenia (3)
Startups (3)
Vaccines (5)
Date
Today (1)
Last 7 days (3)
Last 30 days (16)
Last 365 days (413)
2025 (216)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (341)
Australia (13)
California (61)
Canada (20)
China (13)
Connecticut (4)
Delaware (16)
Europe (621)
Florida (10)
Georgia (2)
Illinois (7)
Indiana (17)
Japan (11)
Maryland (13)
Massachusetts (54)
Minnesota (4)
New Jersey (61)
New York (31)
North Carolina (9)
Northern California (41)
Ohio (2)
Pennsylvania (24)
South America (5)
Southern California (14)
Texas (9)
United States (327)
Utah (6)
Washington State (4)
3,133 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Roche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphoma
June 23, 2025
·
11 min read
Press Releases
Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence
June 18, 2025
·
11 min read
Press Releases
Amgen’s TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom
May 8, 2025
·
8 min read
Press Releases
Taiho Oncology Presents Data at the 2025 American Society of Clinical Oncology Annual Meeting
May 23, 2025
·
6 min read
Press Releases
Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
May 12, 2025
·
6 min read
Press Releases
Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025
June 12, 2025
·
10 min read
Press Releases
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
March 31, 2025
·
7 min read
Press Releases
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
June 16, 2025
·
9 min read
Press Releases
BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors
May 22, 2025
·
19 min read
Press Releases
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer
June 2, 2025
·
12 min read
1 of 314
Next
